リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Fulminant myocarditis in a young woman with mixed connective tissue disease: a case report」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Fulminant myocarditis in a young woman with mixed connective tissue disease: a case report

Hamana, Tomoyo Kawamori, Hiroyuki Satomi-Kobayashi, Seimi Yamamoto, Yuzuru Ikeda, Yoshihiko Hirata, Ken-ichi 神戸大学

2023.04

概要

Background Although cardiac involvement is relatively common in mixed connective tissue disease (MCTD), few reports on MCTD-associated fulminant myocarditis are available. Case summary A 22-year-old woman diagnosed with MCTD was admitted to our institution for cold-like symptoms and chest pain. Echocardiography revealed that the left ventricular ejection fraction (LVEF) had rapidly decreased from 50 to 20%. Because endomyocardial biopsy revealed no significant lymphocytic infiltration, immunosuppressant drugs were not started initially; however, steroid pulse therapy (methylprednisolone, one1000 mg/day) was initiated due to prolonged symptoms and unimproved haemodynamics. Despite strong immunosuppressant therapy, the LVEF did not improve, and severe mitral regurgitation appeared. Three days after steroid pulse therapy initiation, she experienced a sudden cardiac arrest; thus, venoarterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pumping (IABP) were initiated. Subsequent immunosuppressant therapy was continued with prednisolone (100 mg/day) and intravenous cyclophosphamide (1000 mg). Six days after steroid therapy initiation, the LVEF improved to 40% and then recovered to near-normal levels. After successful weaning off of VA-ECMO and IABP, she was discharged. Thereafter, a detailed histopathological examination revealed multi-focal signs of ischaemic micro-circulatory injury and diffuse HLA-DR in the vascular endothelium, suggesting an autoimmune inflammatory response. Discussion We report a rare case of fulminant myocarditis in a patient with MCTD who recovered with immunosuppressive treatment. Despite the absence of significant lymphocytic infiltration findings on histopathological examination, patients with MCTD may experience a dramatic clinical course. Although it is unclear whether myocarditis is triggered by viral infections, certain autoimmune mechanisms may lead to its development.

この論文で使われている画像

参考文献

1. Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, et al. 2019 Diagnostic criteria

for mixed connective tissue disease (MCTD): from the Japan research committee of the

ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol

2021;31:29–33.

2. Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C,

Ahmed S, et al. Cardiac involvement in mixed connective tissue disease: a systematic re­

view. Int J Cardiol 2014;171:326–330.

3. Alpert MA, Goldberg SH, Singsen BH, Durham JB, Sharp GC, Ahmad M, et al.

Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation

1983;68:1182–1193.

4. Lash AD, Wittman AL, Quismorio FP Jr. Myocarditis in mixed connective tissue disease:

clinical and pathologic study of three cases and review of the literature. Semin Arthritis

Rheum 1986;15:288–296.

5. Baldwin WM III, Samaniego-Picota M, Kasper EK, Clark AM, Czader M, Rohde C, et al.

Complement deposition in early cardiac transplant biopsies is associated with ischemic

injury and subsequent rejection episodes. Transplantation 1999;68:894–900.

6. Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev

Rheumatol 2012;8:469–479.

7. Herskowitz A, Ahmed-ansari A, Neumann DA, Beschorner WE, Rose NR, Soule LM,

et al. Induction of major histocompatibility complex antigens within the myocardium

of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll

Cardiol 1990;15:624–632.

8. Wojnicz R, Nowalany-Kozielska E, Wodniecki J, Szczurek-Katań ski K, Noż yń ski J,

Zembala M, et al. Immunohistological diagnosis of myocarditis. Potential role of sarcolem­

mal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myo­

cyte injury. Eur Heart J 1998;19:1564–1572.

Downloaded from https://academic.oup.com/ehjcr/article/7/4/ytad174/7111610 by guest on 02 May 2023

and C4d staining of the myocardium suggested ischaemic microcirculatory injury. The association between micro-circulatory injury

and MCTD-associated myocarditis has not been proven; nonetheless,

myocardial micro-circulatory ischaemia could possibly be related to

myocarditis given that the Raynaud’s syndrome is attributed to extrem­

ity microvascular ischaemia.6

Second, HLA-DR-positive staining was observed in endothelial cells.

Major histocompatibility complexes (MHC) are molecules that play an

important role in presenting antigens, such as viral particles, to the im­

mune system. Increased expression of MHC antigen presentation has

been demonstrated in human tissues undergoing autoimmune injury,

allograft rejection, and other inflammatory states.7 MHC class II

(HLA-DR) antigens are useful markers of autoimmune inflammatory

responses in patients with inflammatory myocardial disease.7,8

Additionally, HLA-DR antigens improve the sensitivity of autoimmune

myocarditis diagnosis because the inflammatory cell infiltration is often

focal and sporadic in distribution, while HLA-DR antigens are distribu­

ted throughout the myocardium.8

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る